SANGAMO THERAPEUTICS, INC (CIK: 0001001233) EDGAR, Information, Filings... CompaniesBIO.Com

SANGAMO THERAPEUTICS, INC

Mailing address
7000 MARINA BLVD, BRISBANE, Delaware, 94005
Phone
5109706000
State location
California
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Filings
N/A

SANGAMO THERAPEUTICS, INC (CIK: 0001001233) is an American company incorporated in the state of California. Head office is located at 7000 MARINA BLVD, BRISBANE, California, 94005. Work in the industry 2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES). SANGAMO THERAPEUTICS, INC is a public company and trade via Over-The-Counter (OTC).

Old names:

SANGAMO BIOSCIENCES INC from 2000-19-May to 2017-06-Jan

Owner	Filings	Transaction Date	Type of Owner
Horn Margaret A	0001294192	Dec-15-2022	director
Beers Courtney	0001955191	Dec-15-2022	director
Dubois-Stringfellow Nathalie	0001947007	Sep-09-2022	officer: SVP-Chief Development Officer
BIOGEN INC.	0000875045	Nov-26-2021	10 percent owner
Biogen MA Inc.	0001810387	Nov-26-2021	10 percent owner
Willoughby Scott B.	0001877368	Aug-02-2021	officer: SVP, Gen. Counsel & Secretary
Fontenot Jason D.	0001851761	Mar-11-2021	officer: SVP, Chief Scientific Officer
Schott Robert J.	0001845310	Feb-01-2021	officer: SVP, Head of Development
Hillan Kenneth J.	0001600359	Sep-09-2020	director
McClung David Mark	0001811505	May-01-2020	officer: EVP Chief Business Officer
Markels John	0001803424	Feb-11-2020	director
Meyers James R	0001387521	Nov-22-2019	director
Lee Sung	0001793200	Oct-31-2019	officer: EVP, Chief Financial Officer
Ramelmeier Rolf Andrew	0001789340	Sep-16-2019	officer: EVP, Technical Operations
LOEB GARY	0001561733	Jul-30-2019	officer: EVP & General Counsel
Duraibabu Prathyusha	0001779092	Jun-13-2019	officer: VP, Principal Acct. Officer
Woolfson Adrian	0001765497	Jan-21-2019	officer: EVP, Research and Development
Boissel Stephane	0001755198	Oct-02-2018	officer: EVP, Corporate Strategy
Smith Karen L.	0001639637	Jun-26-2018	director
Turner Heather D	0001403571	Feb-12-2018	officer: SVP and General Counsel
JEFFS ROGER	0001231615	Jun-26-2017	director
Zakrzewski Joseph S	0001331852	Jun-26-2017	director
Yi Kathy	0001697802	Feb-28-2017	officer: Senior VP & CFO
Herberts Curt A. III	0001691262	Nov-30-2016	officer: Senior VP & CBO
Conner Edward R.	0001691265	Nov-30-2016	officer: Senior VP & CMO
Carey Robert	0001602064	Jun-14-2016	director
Macrae Sandy	0001675687	Jun-01-2016	officer: President and CEO
NICHOL GEOFFREY	0001214505	Dec-07-2015	officer: Executive Vice President, R&D
PARKER H STEWART	0001217456	Jun-22-2015	director
Cleveland Paul B	0001376797	Jun-22-2015	director
DILLY STEPHEN GEORGE	0001389147	Jun-22-2015	director
Mento Steven J	0001324466	Mar-05-2015	director
Ramasastry Saira	0001547959	Feb-12-2015	director
Wolff Henry Ward	0001302390	Jan-12-2015	officer: Exec VP & CFO
ANDO DALE G	0001202278	Jan-05-2015	officer: VP, Therapeutic Dev. & CMO
RINGO WILLIAM R	0001238325	Jan-05-2015	director
Gregory Philip D	0001343543	Jan-02-2015	officer: SVP, Research & CSO
RA Capital Healthcare Fund LP	0001315082	Jun-26-2013	10 percent owner
RA CAPITAL MANAGEMENT, LLC	0001346824	Jun-26-2013	10 percent owner
Kolchinsky Peter	0001384859	Jun-26-2013	10 percent owner
WIGGANS THOMAS G	0001208907	Jun-04-2008	director
Liu Margaret	0001324059	Jun-04-2008	director
Ichikawa David G	0001324506	May-20-2008	officer: Senior VP, Bus. Dev.
Kopp LeRoy C	0001399913	Jul-06-2007	10 percent owner
WOOD MICHAEL C	0001215345	Jun-10-2004	director
GERBER WILLIAM G	0001228634	Jun-10-2004	director
RUTTER WILLIAM J	0001229445	Jun-10-2004	director
LARSON JOHN WILLIAM	0001234387	Jun-04-2004	director
LANPHIER EDWARD O II	0001234386	Dec-15-2003	director, officer: President and CEO
CASE CASEY C	0001234385	Dec-02-2003	officer: Vice President, Research
BLUFORD PETER	0001234384	Oct-16-2003	officer: V.P., Corporate Development
ZANTE GREG	0001264949	Sep-17-2003	officer: Sr Dir., Finance and Admin.
JACOBY JON E M	0001195941	Aug-19-2003	director

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by SANGAMO THERAPEUTICS, INC

Filings	Format	Description	Filed/Effective	File/Film Number
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001415889-24-022312 ( Act) Size: 9 KB	Aug-27-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001415889-24-022310 ( Act) Size: 9 KB	Aug-27-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001415889-24-022308 ( Act) Size: 9 KB	Aug-27-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001415889-24-022307 ( Act) Size: 9 KB	Aug-27-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001415889-24-022306 ( Act) Size: 9 KB	Aug-27-2024
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001193125-24-202234 (34 Act) Size: 41 KB	Aug-16-2024	005-59049 241217890
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001415889-24-021365 ( Act) Size: 6 KB	Aug-15-2024
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001628280-24-035165 (34 Act) Size: 5337 KB	Aug-06-2024	000-30171 241179020
8-K	Document	Current report filing Acc-no: 0001628280-24-035160 (34 Act) Size: 345 KB	Aug-06-2024	000-30171 241178976
8-K	Document	Current report filing Acc-no: 0001628280-24-032815 (34 Act) Size: 281 KB	Jul-24-2024	000-30171 241138106
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001086364-24-008122 (34 Act) Size: 12 KB	Jul-08-2024	005-59049 241105133
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001415889-24-016686 ( Act) Size: 6 KB	Jun-13-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001415889-24-015762 ( Act) Size: 7 KB	Jun-06-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001415889-24-015761 ( Act) Size: 7 KB	Jun-06-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001415889-24-015759 ( Act) Size: 7 KB	Jun-06-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001415889-24-015757 ( Act) Size: 7 KB	Jun-06-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001415889-24-015755 ( Act) Size: 7 KB	Jun-06-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001415889-24-015754 ( Act) Size: 7 KB	Jun-06-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001415889-24-015753 ( Act) Size: 7 KB	Jun-06-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001415889-24-015752 ( Act) Size: 7 KB	Jun-06-2024

Recent 20 filings. View all SANGAMO THERAPEUTICS, INC filings

Overall rating 5.0

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

SANGAMO THERAPEUTICS, INC overview
SANGAMO THERAPEUTICS, INC job
SANGAMO THERAPEUTICS, INC stock
SANGAMO THERAPEUTICS, INC ownership
SANGAMO THERAPEUTICS, INC CEO
SANGAMO THERAPEUTICS, INC documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.